These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32424891)

  • 1. Opportunistic virus infections in psoriasis patients: The safer alternative of apremilast in the COVID-19 era.
    Armesto S; González Vela C; González López MA
    Dermatol Ther; 2020 Jul; 33(4):e13618. PubMed ID: 32424891
    [No Abstract]   [Full Text] [Related]  

  • 2. Patient-Driven Discontinuation of Apremilast During the COVID-19 Pandemic in Two Canadian Academic Hospital Clinics and One Community Practice.
    Georgakopoulos JR; Vender R; Yeung J
    J Cutan Med Surg; 2020; 24(4):418-419. PubMed ID: 32396018
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management.
    Mugheddu C; Pizzatti L; Sanna S; Atzori L; Rongioletti F
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e376-e378. PubMed ID: 32385859
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical efficacy, speed of improvement and safety of apremilast for the treatment of adult Psoriasis during COVID-19 pandemic.
    Melis D; Mugheddu C; Sanna S; Atzori L; Rongioletti F
    Dermatol Ther; 2020 Jul; 33(4):e13722. PubMed ID: 32475036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 in an elderly patient treated with secukinumab.
    Di Lernia V; Bombonato C; Motolese A
    Dermatol Ther; 2020 Jul; 33(4):e13580. PubMed ID: 32406078
    [No Abstract]   [Full Text] [Related]  

  • 6. Covid-19 infection in psoriasis patients treated with cyclosporin.
    Di Lernia V; Goldust M; Feliciani C
    Dermatol Ther; 2020 Jul; 33(4):e13739. PubMed ID: 32478942
    [No Abstract]   [Full Text] [Related]  

  • 7. Dermatologic treatments in the era of COVID-19 pandemic-Data and Hypothesis.
    Sadoughifar R; Goldust M; Kroumpouzos G; Szepietowski JC; Lotti T; Sandhu S
    Dermatol Ther; 2020 Jul; 33(4):e13562. PubMed ID: 32396251
    [No Abstract]   [Full Text] [Related]  

  • 8. IBD in the COVID-19 era: the value of international collaboration.
    Brenner EJ; Ungaro RC; Colombel JF; Kappelman MD
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):887-888. PubMed ID: 32941833
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience.
    Gisondi P; Facheris P; Dapavo P; Piaserico S; Conti A; Naldi L; Cazzaniga S; Malagoli P; Costanzo A
    Br J Dermatol; 2020 Aug; 183(2):373-374. PubMed ID: 32343839
    [No Abstract]   [Full Text] [Related]  

  • 10. Balancing aesthetic and conventional dermatology practice in the COVID-19 era.
    Arora G; Jafferany M; Arora S
    Dermatol Ther; 2020 Jul; 33(4):e13620. PubMed ID: 32431094
    [No Abstract]   [Full Text] [Related]  

  • 11. Biologic therapy for psoriasis during the COVID-19 outbreak: The choice is to weigh risks and benefits.
    Conforti C; Giuffrida R; Dianzani C; Di Meo N; Zalaudek I
    Dermatol Ther; 2020 Jul; 33(4):e13490. PubMed ID: 32358864
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial note about SARS-CoV-2 in the pandemic era.
    Gómez LA
    Biomedica; 2020 Oct; 40(Supl. 2):14-15. PubMed ID: 33152183
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of Coronavirus Disease 2019 and Pandemics on Global Surgical Outreach.
    Azizzadeh K; Hamdan US; Salehi PP
    JAMA Otolaryngol Head Neck Surg; 2020 Sep; 146(9):783-784. PubMed ID: 32614435
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic isotretinoin therapy in the era of COVID-19.
    Abdelmaksoud A; Vestita M; El-Amawy HS; Ayhan E; An İ; Öztürk M; Goldust M
    Dermatol Ther; 2020 Jul; 33(4):e13482. PubMed ID: 32358858
    [No Abstract]   [Full Text] [Related]  

  • 15. The Use of Nonsteroidal Anti-inflammatory Drugs in Urological Practice in the COVID-19 Era: Is "Safe Better than Sorry"?
    Pradère B; Ploussard G; Catto JWF; Rouprêt M; Misrai V
    Eur Urol; 2020 Aug; 78(2):134-135. PubMed ID: 32284245
    [No Abstract]   [Full Text] [Related]  

  • 16. Should biologics for psoriasis be interrupted in the era of COVID-19?
    Lebwohl M; Rivera-Oyola R; Murrell DF
    J Am Acad Dermatol; 2020 May; 82(5):1217-1218. PubMed ID: 32199889
    [No Abstract]   [Full Text] [Related]  

  • 17. Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic.
    Mauri D; Kamposioras K; Tolia M; Alongi F; Tzachanis D;
    Lancet Oncol; 2020 Jun; 21(6):759-760. PubMed ID: 32410877
    [No Abstract]   [Full Text] [Related]  

  • 18. Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.
    Narasaraju T
    Ann Intern Med; 2020 Aug; 173(4):323-324. PubMed ID: 32805179
    [No Abstract]   [Full Text] [Related]  

  • 19. Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.
    Zhang H; Wang CY; Zhou P; Yue H; Du R
    Ann Intern Med; 2020 Aug; 173(4):324. PubMed ID: 32805177
    [No Abstract]   [Full Text] [Related]  

  • 20. Being a Urologist on COVID-19 Pandemic Days.
    Özman O
    Urol J; 2020 Sep; 17(5):555-556. PubMed ID: 32920813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.